Orexigen revisits Fen-phen…
Wednesday, January 13th, 2010Today is a big day for Orexigen Therapeutics’ (OREX) CEO Mike Narachi. At 1:30 p.m. EST he is scheduled to present at JPMorgan’s big Healthcare Conference in San Francisco. Narachi will have only a brief half hour to explain, or perhaps gloss over the 30-page slideshow that the company filed as an 8K on Monday. It’s [...]

